Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ANPMF > SEC Filings for ANPMF > Form 8-K on 19-Mar-2013All Recent SEC Filings

Show all filings for ANGIOTECH PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ANGIOTECH PHARMACEUTICALS INC


19-Mar-2013

Triggering Events That Accelerate or Increase a Direct Financial Ob


Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

On March 18, 2013, Angiotech Pharmaceuticals, Inc., a corporation organized under the laws of British Columbia ("Angiotech" or the "Company"), announced that, Deutsche Bank National Trust Company as trustee (the "Trustee") under the Indenture (as defined below), issued a notice of redemption, filed herewith as Exhibit 99.1 and incorporated herein by this reference, to the record holder of the Company's Senior Secured Floating Rate Notes due 2013 (the "Notes", CUSIP Number 034918AH5) on behalf of Angiotech to redeem $16.0 million in aggregate principal amount of the Notes. The redemption price for the Notes is equal to 100% of principal amount of the Notes, together with any accrued and unpaid interest on the principal amount of the Notes to, but excluding, the redemption date, which is April 17, 2013. On the redemption date, the redemption price for the Notes will become due and payable. As of the date hereof, there are approximately $60.0 million in aggregate principal amount of Notes outstanding.

The Company issued the Notes under that certain Indenture dated as of May 12, 2011, by and among the Company, as issuer, certain subsidiaries of the Company as guarantors referred to therein and the Trustee, as supplemented by that certain Supplemental Indenture, dated as of August 13, 2012, among the Company, the guarantors referred to therein, and the Trustee (the indenture, as supplemented, referred to as the "Indenture"). The redemption will be made pursuant to the terms of the Indenture.



Item 8.01. Other Events.

On March 18, 2013, Angiotech issued a press release announcing the partial redemption of the Notes. A copy of Angiotech's press release is furnished as Exhibit 99.2 to this Current Report on Form 8-K.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are filed herewith:

Exhibit                           Description

 99.1     Notice of Optional Partial Redemption dated March 18, 2013.

 99.2     Press Release, dated March 18, 2013.


  Add ANPMF to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ANPMF - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.